Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimum Effective Volume (MEV95%) of Ropivacaine 7.5 mg/ml to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus

NCT03329456 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT03329456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03329456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimum Effective Volume (MEV95%) of Ropivacaine 7.5 mg/ml to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus
Lead sponsor
University Hospital of North Norway
Phase
Phase 4
Overall status
Completed
Start date
October 30, 2017
Completion date
April 1, 2018
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, shoulder disease